- Home
- APAD vs FENC Comparison
APAD vs FENC Comparison
Compare APAD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$9.94
Company Overview
Basic Information| Metric | APAD | FENC |
|---|---|---|
| Founded | 2022 | 1996 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.0M | 230.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | APAD | FENC |
|---|---|---|
| Price | $8.07 | $9.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 106.5K | ★ 365.1K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | ★ $60.17 | $986.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.50 | $5.65 |
| 52 Week High | $14.00 | $10.45 |
Technical Indicators
Market Signals| Indicator | APAD | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 21.76 | 74.32 |
| Support Level | N/A | $7.45 |
| Resistance Level | $10.16 | $10.18 |
| Average True Range (ATR) | 1.00 | 0.65 |
| MACD | -0.12 | 0.08 |
| Stochastic Oscillator | 8.15 | 84.86 |
Price Performance
Historical Comparison APAD
FENC
About APAD A Paradise Acquisition Corp. Class A Ordinary Shares
A Paradise Acquisition Corp is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.